Madrigal Pharmaceuticals Inc. (MDGL) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Madrigal Pharmaceuticals ...

    NASDAQ: MDGL · Real-Time Price · USD
    443.01
    -6.63 (-1.47%)
    At close: Oct 03, 2025, 3:59 PM
    450.00
    1.58%
    After-hours: Oct 03, 2025, 07:29 PM EDT

    Madrigal Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    PE Ratio
    		 -14.09 -11.57 -16.84 -5.79
    PEG Ratio
    		 -1.47 -0.72 -0.95 -0.49
    PS Ratio
    		 36.44 n/a n/a n/a
    PB Ratio
    		 8.70 10.67 25.20 7.14
    P/FCF Ratio
    		 -14.36 -13.28 -22.1 -7.61
    P/OCF Ratio
    		 -14.41 -13.34 -22.12 -7.62
    OCF/S Ratio
    		 -2.53 n/a n/a n/a
    Debt / Equity Ratio
    		 0.16 0.29 0.25 0.00
    Quick Ratio
    		 5.90 5.38 3.12 3.54
    Current Ratio
    		 6.10 5.38 3.12 3.54
    Asset Turnover
    		 0.17 n/a n/a n/a
    Interest Coverage
    		 -33.94 -29.93 -74.06 n/a
    Return on Equity
    		 -0.62 -0.92 -1.5 -1.23
    Return on Assets
    		 -0.45 -0.58 -0.81 -0.88
    Return on Invested Capital
    		 -0.57 -0.73 -1.19 -1.23
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.96 n/a n/a n/a
    Net Profit Margin
    		 -2.59 n/a n/a n/a
    Pretax Profit Margin
    		 -2.59 n/a n/a n/a
    Operating Profit Margin
    		 -2.76 n/a n/a n/a
    FCF Margin
    		 -2.54 n/a n/a n/a
    EBITDA Margin
    		 -2.5 n/a n/a n/a

    Add to Watchlist